Stocktoria
ELI LILLY & Co LLY
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 1970-07-09
ELI LILLY & Co statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net margin | 31.7% | 23.5% | 15.4% | 21.9% | 19.7% |
| Return on assets | 18.4% | 13.5% | 8.2% | 12.6% | 11.4% |
| Return on equity | 77.8% | 74.2% | 48.2% | 58.0% | 61.0% |
| Debt / equity | 1.54× | 2.07× | 1.76× | 1.37× | 1.83× |
| Current ratio | 1.58 | 1.15 | 0.94 | 1.05 | 1.23 |
| Revenue growth | 44.7% | 32.0% | 19.6% | 0.8% | 15.4% |
Source: SEC EDGAR filings · CIK 0000059478 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.